Albemarle Shares Drop: Understanding the Fluctuations of the Lithium Mining Company.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 21 2025
0mins
Should l Buy ALB?
Source: Barron's
Stock Performance: Albemarle's shares experienced a decline for the second consecutive day.
Market Influences: The drop in stock price is attributed to potential changes in global lithium supply.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALB
Wall Street analysts forecast ALB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALB is 149.79 USD with a low forecast of 85.00 USD and a high forecast of 210.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
20 Analyst Rating
10 Buy
10 Hold
0 Sell
Moderate Buy
Current: 156.480
Low
85.00
Averages
149.79
High
210.00
Current: 156.480
Low
85.00
Averages
149.79
High
210.00
About ALB
Albemarle Corporation is engaged in transforming essential resources into critical ingredients for mobility, energy, connectivity, and health. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). It serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- DuPont Earnings Expectations: DuPont is expected to report earnings of $0.43 per share and revenue of $1.69 billion for Q4 2025, with analysts noting ongoing pressure in short-cycle businesses, while slight improvements in the automotive sector may influence investor sentiment.
- Cisco's AI Focus: Cisco anticipates earnings of $1.02 per share and revenue of $15.1 billion for Q2 FY2026, with CEO highlighting a major multi-year campus networking refresh, making AI infrastructure demand a critical growth driver.
- Importance of Employment Report: The January employment report is expected to show an addition of 80,000 nonfarm payrolls and an unchanged unemployment rate of 4.4%, directly impacting private consumption and U.S. GDP, making it crucial for investors to monitor.
- Consumer Price Index Insights: The January CPI is projected to increase by 2.5% year-over-year, with core CPI rising by 2.6%, providing essential inflation details despite not being the Fed's preferred measure, particularly regarding persistent shelter cost inflation.
See More

- Market Performance: The Dow Jones Industrial Average rose by 2.5% and closed above 50,000 for the first time.
- Nasdaq Struggles: In contrast, the Nasdaq Composite ended the week down 1.8%, despite a strong rally on Friday.
See More
- Surge in Investments: The Trump administration has made unprecedented equity investments in at least 10 companies over the past year, including critical minerals and chipmakers, aiming to build a domestic supply chain and reduce reliance on China, indicating a proactive government role in economic strategy.
- U.S. Steel Golden Share: The administration secured a golden share in U.S. Steel as a condition for approving Nippon Steel's acquisition, granting the president veto power over key business decisions, which ensures stability and growth in the U.S. steel industry, reflecting direct government intervention in vital sectors.
- Strategic Deal with MP Materials: The Defense Department struck a landmark deal with MP Materials, investing $400 million in preferred stock with rights to purchase additional shares, positioning the Pentagon as the largest single shareholder and further solidifying U.S. dominance in the rare earth mining sector.
- L3Harris and Defense Partnership: L3Harris announced a proposed partnership with the U.S. government, where the Pentagon will invest $1 billion in its rocket motor business, with plans for an IPO in the second half of 2026, allowing the Pentagon's investment to convert into common equity, enhancing the capital base of the defense industry.
See More
- Job Data Expectations: The U.S. is expected to add 60,000 jobs in January, up from 50,000 in December, which could influence the Fed's monetary policy direction amidst ongoing economic uncertainty.
- Inflation Metrics Analysis: The January Consumer Price Index is projected to rise by 0.29% month-over-month and 2.5% year-over-year, showing improvement but still falling short of the Fed's 2% target, potentially affecting investor rate expectations.
- Market Reaction and Risks: Recent signs of labor market weakness, including an ADP report indicating only 22,000 new private sector jobs, may heighten expectations for further Fed rate cuts, although investors remain optimistic about economic resilience.
- Stock Market Rotation Trend: A significant rotation within the stock market is underway, with the Dow Jones Industrial Average rising over 2% this week, reflecting confidence in economic recovery, despite ongoing weakness in tech stocks.
See More
- Dividend Growth Rating Overview: According to Seeking Alpha's scoring system, companies like Albemarle, Amkor Technology, Baxter International, Pfizer, and Paramount Skydance received an F grade for dividend growth, indicating a lack of commitment to increasing shareholder returns, which may lead to decreased investor confidence.
- Industry Distribution: These low-rated stocks span various sectors, including specialty chemicals, pharmaceuticals, healthcare equipment, broadcasting, and REITs, reflecting a general weakness in dividend growth capabilities among many large companies under varying market conditions.
- Impact Analysis: All listed stocks are categorized as 'Sell', suggesting that investors should exercise caution when considering investments in these companies, particularly given their poor performance in dividend growth, which could adversely affect their long-term stock performance.
- Rating Standard Interpretation: Seeking Alpha's dividend growth ratings use a scale from A+ to F, with grades of B- or above considered a Buy, while D+ or below is deemed a Sell, highlighting a significant deficiency in these companies' commitment to shareholder returns, potentially impacting their attractiveness.
See More
- Mining Stocks Surge: Ahead of the upcoming U.S. mining conference, MP Materials saw a 9.3% increase, with a nearly 30% rise year-to-date in 2026, indicating heightened market interest and demand for critical minerals, which may drive future investments and expansions for the company.
- Software Sector Decline: The S&P Software and Services sector dropped nearly 4% on Tuesday, with Cognizant plummeting 10%, reflecting investor concerns over the impact of artificial intelligence, which could undermine confidence in software companies and affect their growth potential moving forward.
- Walmart Hits $1 Trillion Market Cap: Walmart crossed the $1 trillion market cap for the first time on Tuesday, with shares up 25% over the past three months, indicating a strong recovery in the retail sector under new CEO John Furner, which may attract more investor interest.
- Biotech Earnings Reports Ahead: Eli Lilly and AbbVie are set to report earnings on
See More










